Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$76.51 USD
+3.01 (4.10%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $76.81 +0.30 (0.39%) 8:10 AM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 181 - 200 ( 529 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Coronavirus Crisis Update- Infections Moving West
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 24 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology: Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 17 2020
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for GILD.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department